Fletchers acquires consumer acquisition specialist Blume

We are excited to share our latest acquisition; Blume, a leading customer acquisition specialist for the legal sector.

Once the transaction completes, Blume will join an expanded Fletchers Group and take responsibility for Fletchers’ consumer operations including The Medical Law Network, a marketing network for medical negligence law firms owned by Fletchers and its customer-facing brand, Patient Claim Line.

The latest announcement comes off the back of Blume completing its first significant acquisition of Online Legal, and follows a record year of growth with the business doubling in headcount and turnover. A funding boost earlier this year from Rockpool Investments, who will now exit the business, has helped Blume develop new product offers, expand its technology capabilities and recruit a strong multi-skilled team.

Following the acquisition, Blume Group’s Chief Executive Dez Derry will continue to lead Blume and join a wider Group leadership team, which will also include Blume’s Chief Operating Officer Steve Evans and Fletchers’ Chief Marketing Officer Alex Kenny.

Peter Haden, CEO of Fletchers Group says: “The acquisition of Blume brings a high quality, growth-focused business to the Group and creates the UK’s leading medical negligence customer acquisition specialists in the UK.

“While our legal practice will operate as a separate entity, we are two highly complementary teams and big champions of the benefits that technology can bring to the sector, both as suppliers to law firms and to improve our service to clients. We are looking forward to working with Dez and Steve to support Blume’s growth, and to accelerate its market presence by leveraging our brands and customer acquisition expertise. In addition, Fletchers will continue to invest in growing our legal practice, with a focus on Serious Personal Injury, Medical Negligence and Court of Protection.”

Derry says: “We are thrilled to be partnering with Sun and Fletchers who share our vision, ambition and appetite for innovation. This is a landmark transaction for Blume which will take the business to the next level, giving us the ability to rapidly grow our foundation in partnership with a very strong capital partner.”

The deal is subject to approval from the Financial Conduct Authority.